Nutritional Intake in Patients on Noninvasive Ventilation: a Prospective Observational Study (PRO-NUTRINIV)

December 19, 2024 updated by: Francesca Moretto, Università degli Studi del Piemonte Orientale Amedeo Avogadro

Nutrition in Critically Ill Patients Undergoing Non-Invasive Ventilation: a Prospective Single-Center Study

The primary objective is to quantify the caloric and protein intake in adult participants with acute respiratory failure who start a noninvasive ventilation treatment. The main question is:

- Are participants meeting their caloric and protein target during noninvasive ventilation treatment? Participants will complete a five-day food diary collection starting from the initiation of noninvasive ventilation treatment.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Background:

Nutrition is a fundamental component of Intensive Care Unit (ICU) therapy. Critically ill patients have an increased risk of developing malnutrition early from the ICU admission, a factor strongly associated with higher risks of complications, prolonged ICU/hospital stays, and increased ICU readmission and mortality rates. Malnutrition in critical patients occurs due to underlying acute disease, leading to elevated catabolic stress. The use of noninvasive ventilation (NIV) has significantly increased over the past twenty years, becoming a cornerstone of acute respiratory failure (ARF) treatment. Respiratory support is provided through an interface, usually a mask or a helmet, which often poses a significant obstacle to nutrition delivery, making oral intake impossible and necessitating the initiation of enteral (EN) or parenteral nutrition (PN). These methods can both increase patient discomfort due to nasogastric (NG) tube and central line positioning and management. While critical care guidelines for nutritional management of mechanically ventilated patients are well established, data and recommendations for patients on NIV are still limited. A retrospective study conducted by our team in the intensive care unit (data not yet published) revealed a malnutrition prevalence of 70% among patients undergoing NIV on the fifth day of hospitalization.

Objectives of the Study:

The primary objective of this study is to quantify the caloric and protein intake of patients undergoing noninvasive ventilation (NIV) in intensive care units, sub-intensive care units, and hospital wards. Secondary objectives are to assess the potential association between clinical characteristics, nutritional therapy features, and the failure to achieve caloric and protein intake targets, to evaluate complications associated with NIV to analyze differences between the actual caloric and protein intake and the recommended targets based on the type of respiratory failure (hypoxemic vs. hypoxemic-hypercapnic) for which NIV treatment is initiated.

Methods:

A monocentric prospective observational study to be conducted in the general intensive care unit (ICU), intermediate care unit of Emergency Medicine and Surgery (MECAU), Cardiology Intermediate Care Unit, cardiology and internal medicine wards of the University Hospital Maggiore della Carità in Novara.

The study will include adult patients admitted to the specified units who undergo NIV treatment for acute respiratory failure caused by various conditions (e.g., cardiogenic pulmonary edema, pneumonia, exacerbation of chronic obstructive pulmonary disease). All patients admitted to the hospital requiring the initiation of noninvasive ventilation (NIV) for acute respiratory failure within 24 hours of admission will be evaluated for inclusion in the study.

For all patients meeting the prespecified inclusion criteria and without exclusion criteria, the following data will be collected:

  • Patient related data: demographic and biometric characteristics, i.e. age, sex, height (reported by the patient or a family member), weight, body mass index (BMI), calf circumference, and any weight loss over the last six months; admission diagnosis and the cause of acute respiratory failure requiring NIV treatment; comorbidities; NRS 2002 (Nutritional Risk Screening) score; laboratory values; documentation of any pressure ulcers present before NIV initiation.
  • Food Diary: documentation of the actual composition of meals consumed (breakfast, lunch, dinner, and other), with precise quantification of food and liquid intake to create a five-day food diary, collected by nurses or healthcare workers (OSS) responsible for meal delivery, noting who selects the meal (patient or healthcare provider); reasons for any missed meals and the presence of fever (with the recorded temperature) will also be documented to define the patient's daily catabolic status. Caloric and protein intake will later be calculated based on the food diary in collaboration with the hospital's Dietetics and Clinical Nutrition Service.
  • NIV Treatment: settings, interface used, hours of ventilation and other devices used during breaks or meals, complications during treatment.
  • Hospitalization Data: length of hospital stay and in-hospital mortality. Data Collection Tools: clinical data will be recorded in a specific data collection form (attached) completed by the nursing, OSS, and medical staff involved in the study, while laboratory and hospitalization data will be gathered from hospital programs accessible via the University Hospital Maggiore della Carità's internal network.

Sample Size: a retrospective study conducted by our team in the intensive care unit (data not yet published) revealed a malnutrition prevalence of 70% among patients undergoing NIV on the fifth day of hospitalization. With a confidence level of 95%, a sample size of 126 subjects is required to estimate a malnutrition prevalence of 70% on the fifth day of NIV initiation with a precision of ±8%.

Statistical Analysis: descriptive statistics will be used to summarize the characteristics of the included patients, categorical variables will be presented as numbers and percentages, while continuous variables will be expressed as means (± standard deviation, SD) or medians [interquartile range, IQR]. T-test or Mann-Whitney U test will be applied for differences between means or medians of continuous variables, respectively, while Chi-square or Fisher's exact test will be used for categorical variables. For comparisons involving more than two groups analysis of variance (ANOVA) or Kruskal-Wallis test will be employed for continuous variables and Chi-square test will be used for categorical variables with multiple comparisons. A multivariable regression model will be applied to examine associations between clinical outcomes (dependent variables) and patient clinical characteristics or nutritional therapy features (independent variables). A p-value of <0.05 will be considered statistically significant for all analyses.

Study Type

Observational

Enrollment (Estimated)

126

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Novara, Italy, 28100
        • Azienda Ospedaliero Universitaria Maggiore della Carità
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients admitted to the participant wards, intermediate or intensive care units for acute respiratory failure from any cause, undergoing noninvasive ventilation within 24 hours from hospital admission and without exclusion criteria, will be considered for enrollment.

Description

Inclusion Criteria:

  • Age of 18 years or more
  • Hospitalization in the participant ordinary wards, intermediate care units and intensive care unit at the Maggiore della Carità University Hospital, Novara, Italy
  • Admission for acute respiratory failure of any cause requiring noninvasive ventilation treatment within 24 hours from hospital admission

Exclusion Criteria:

  • Palliative noninvasive ventilation treatment
  • Contraindication to oral nutrition from hospital admission
  • Patients admitted for surgical or gastroenterological diagnosis
  • Severe immunocompromised patients or patients undergoing therapies contraindicating oral nutrition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Noninvasively ventilated patients
For patients admitted with acute respiratory failure requiring noninvasive ventilation, a food diary will be collected for five days.
A food and beverage diary will be collected for five days starting from the initiation of noninvasive ventilation, with caloric and protein intake quantified by a Nutrition Physician Specialist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caloric intake
Time Frame: Data will be collected on a daily food diary for five days from the start of noninvasive ventilation treatment
Analysis of daily caloric intake per kilogram in patients undergoing noninvasive ventilation for acute respiratory failure
Data will be collected on a daily food diary for five days from the start of noninvasive ventilation treatment
Protein intake
Time Frame: Data will be collected on a daily food diary for five days from the start of noninvasive ventilation treatment
Analysis of daily protein intake per kilogram in patients undergoing noninvasive ventilation for acute respiratory failure.
Data will be collected on a daily food diary for five days from the start of noninvasive ventilation treatment
Caloric and protein adequacy
Time Frame: Discrepancy will be analyzed daily for five days from the start of noninvasive ventilation treatment
Analysis of the discrepancy between patients' actual caloric and protein intake and the caloric and protein target recommended in the critically ill patients guidelines.
Discrepancy will be analyzed daily for five days from the start of noninvasive ventilation treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk factors for undernutrition
Time Frame: This evaluation will consider undernutrition as a dichotomous outcome during the five days of data collection
Evaluation of potential associations between patient clinical and nutritional characteristics and undernutrition
This evaluation will consider undernutrition as a dichotomous outcome during the five days of data collection
Noninvasive ventilation complications
Time Frame: Complication occurrence will be evaluated during the five days of data collection
Occurrence of noninvasive ventilation treatment-related complications
Complication occurrence will be evaluated during the five days of data collection
Caloric and protein adequacy
Time Frame: Discrepancy will be analyzed daily for five days from the start of noninvasive ventilation treatment
Analysis of the discrepancy between patients' actual caloric and protein intake and the caloric and protein target recommended in the critically ill patients guidelines, according to the type of respiratory failure, hypoxemic vs hypoxemic-hypercapnic.
Discrepancy will be analyzed daily for five days from the start of noninvasive ventilation treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 16, 2024

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

December 14, 2024

First Submitted That Met QC Criteria

December 14, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 19, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Failure

Clinical Trials on Food diary

Subscribe